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Introduction: Parity-identified mammary epithelial cells (PI-MECs) are an interesting cellular subset because they
survive involution and are a presumptive target for transformation by human epidermal growth factor receptor 2
(HER2)/neu in mammary tumors. Depending on the type of assay, PI-MECs have been designated lobule-restricted
progenitors or multipotent stem/progenitor cells. PI-MECs were reported to be part of the basal population of
mammary epithelium based on flow cytometry. We investigated the cellular identity and lineage potential of PI-
MECs in intact mammary glands.
Methods: We performed a quantitative and qualitative analysis of the contribution of PI-MECs to mammary epithelial
cell lineages in pregnant and involuted mammary glands by immunohistochemistry, fluorescence-activated cells
sorting (FACS), and quantitative polymerase chain reaction. PI-MECs were labeled by the activation of Whey Acidic
Protein (WAP)-Cre during pregnancy that results in permanent expression of yellow fluorescent protein.
Results: After involution, PI-MECs are present exclusively in the luminal layer of mammary ducts. During pregnancy,
PI-MECs contribute to the luminal layer but not the basal layer of alveolar lobules. Strikingly, whereas all luminal
estrogen receptor (ER)-negative cells in an alveolus can be derived from PI-MECs, the alveolar ER-positive cells are
unlabeled and reminiscent of Notch2-traced L cells. Notably, we observed a significant population of unlabeled alveolar
progenitors that resemble PI-MECs based on transcriptional and histological analysis.
Conclusions: Our demonstration that PI-MECs are luminal cells underscores that not only basal cells display
multi-lineage potential in transplantation assays. However, the lineage potential of PI-MECs in unperturbed
mammary glands is remarkably restricted to luminal ER-negative cells of the secretory alveolar lineage. The
identification of an unlabeled but functionally similar population of luminal alveolar progenitor cells raises the
question of whether PI-MECs are a unique population or the result of stochastic labeling. Interestingly, even
when all luminal ER-negative cells of an alveolus are PI-MEC-derived, the basal cells and hormone-sensing
cells are derived from a different source, indicating that cooperative outgrowth of cells from different lineages
is common in alveologenesis.* Correspondence: mathijs.voorhoeve@gmail.com; apietersen@gmail.com
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Mammary epithelium is maintained by a pool of stem or
progenitor cells that upon asymmetric cell division undergo
a process of lineage restriction to generate the different
epithelial cell types therein [1,2]. The existence of lineage-
restricted cell populations in mammary epithelium has long
been recognized [3,4], and because the molecular portraits
of breast tumors revealed a clear separation of breast can-
cer subtypes based on lineage characteristics [5], there has
been a concerted effort in recent years to map the mam-
mary stem cell hierarchy [6]. However, the extent of lineage
restriction and parent-progeny relationships in this hier-
archy are still unclear because most of the data showing
multi- or bi-lineage potential has been obtained by isolating
single mammary epithelial cells and evaluating their
progeny either in vitro or by transplantation into de-
epithelialized mammary fat pads. For example, several
groups have shown that cells belonging to the basal popu-
lation (based on cell surface markers) have the potential
to generate all mammary epithelial cell types when trans-
planted by themselves in cleared mammary fat pads, and
these cells are referred to as mammary stem cells [7-9].
However, lineage-tracing techniques using a basal cell-
specific promoter to permanently label basal cells in intact
mammary glands showed that these cells gave rise only to
basal progeny but not to cells belonging to the luminal
layer [10]. Therefore, lineage potential appears to be more
restricted in unperturbed tissue.
Another subpopulation of mammary epithelial cells,
parity-identified mammary epithelial cells (PI-MECs), has
also been shown to have multi-lineage potential in trans-
plantation assays [11]. In the intact mammary gland, how-
ever, it is unclear where PI-MECs are positioned in the
lineage hierarchy. PI-MECs are an interesting cell popula-
tion because they are long-lived and have been suggested
to be the cancer cell of origin in Her2/neu-driven tumori-
genesis [12-14]. PI-MECs are identified by a reporter
which is irreversibly activated through Cre-mediated
recombination [15]. The Cre recombinase is expressed
under control of the whey acidic protein (WAP) promoter,
which is strongly induced during pregnancy and through-
out lactation [16,17]. After weaning, the secretory milk-
producing cells are removed during a process termed
involution [18] and WAP expression becomes undetect-
able by Western blot [19]. Unexpectedly, initial studies
using WAP-Cre and LacZ-reporter mice showed that not
all cells that expressed WAP during lactation are removed,
but in fact a significant portion of LacZ+ cells survived the
involution process [15]. These LacZ+ cells were found to
be a major source for the newly developing structures re-
quired for milk production in subsequent pregnancies
[15] and are now referred to as PI-MECs [6].
In the virgin (nulliparous) mouse or in a mouse that has
completed the involution process after weaning (parous),the mammary epithelium consists mainly of bi-layered
milk ducts [1]. The outer basal layer contains contractile
myoepithelial cells as well as the mammary stem cells, and
the luminal layer contains both steroid receptor-positive
and -negative cells. The steroid receptor-positive cells, or
hormone-sensing cells, relay systemic growth signals such
as estrogen, progesterone, and prolactin via paracrine
signals to neighboring cells, thereby orchestrating dy-
namic changes in mammary gland morphology [20,21].
Under the influence of pregnancy-induced hormone
surges, side branches sprout from the epithelial ducts. On
these side branches, lobules of alveoli are formed to
become the sites of milk production [20]. LacZ-staining
demonstrated a clear contribution of PI-MECs to these al-
veolar lobules and PI-MECs are therefore also referred to
as lobule-limited progenitors [6]. In these analyses based
on intact mammary glands, PI-MECs are presumed to
generate both the basal and luminal cells that make up the
alveoli [6]. Interestingly, transplantation studies of un-
sorted mammary epithelial cells showed that PI-MECs
can generate all mammary epithelial cell types. However,
they had a limited capacity for self-renewal when out-
growths consisted of PI-MECs only and therefore they
were designated stem/progenitor cells [11]. Fluorescence-
activated cell sorting (FACS) studies on cultured primary
cells suggested that PI-MECs are part of the basal popula-
tion [22], in line with the position of the mammary stem
cells [8].
In the study presented here, we used a fluorescent re-
porter gene to analyze the cellular identity and lineage con-
tribution of PI-MECs in unperturbed mammary glands.
We demonstrate by both FACS and histology that PI-
MECs are steroid receptor-negative luminal cells of the al-
veolar lineage. Their characteristics are indistinguishable
from those of unlabeled alveolar progenitor cells of the
same mammary gland. During pregnancy, PI-MECs con-
tribute steroid receptor-negative luminal cells, but not
hormone-sensing or basal cells, to developing alveoli.
Methods
Mice
WAP-Cre mice (Jax#008735) [23] and Rosa26-lox-Stop-
lox-YFP mice [24] were backcrossed up to four genera-
tions on an FVB background. All of the mice used in
this study contain one allele each of the WAP-Cre and
Rosa-lsl-YFP transgenes. For timed matings, female mice
were placed in the cage of a male after 5 p.m. and
checked for vaginal plugs at 9 a.m. the following morn-
ing (day 0). Mice were euthanized by carbon dioxide
inhalation and immediately dissected for thoracic (#3),
abdominal (#4), and inguinal (#5) mammary glands at
the indicated time points. All animal protocols were ap-
proved by the SingHealth Institute for Animal Care and
Use Committee.
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glands
Thoracic glands were whole mount-photographed on an
Olympus SZX-12 fluorescent stereoscopic microscope
with green fluorescent protein (GFP) filter (Olympus,
Tokyo, Japan), and images were acquired by DP2-BSW
software through an Olympus DP72 CCD detector. One
#3 gland was subsequently fixed overnight in 4% buff-
ered formaldehyde (ICM Pharma, Singapore) for paraffin
embedding. The other #3 gland was fixed 1.5 hours in
2% formaldehyde in phosphate-buffered saline, prior to
embedding in Tissue Tek OCT (Sakura Finetek, Tokyo,
Japan) for cryopreservation. Cryosections (15 to 30 μm)
were cut on a Leica CM1950 cryostat onto SuperFrost Plus-
coated slides (Menzel-Gläser, Braunschweig, Germany), and
stained with Rhodamine-conjugated phalloidin (Molecular
Probes, now part of Invitrogen Corporation, Carlsbad,
CA, USA) in accordance with the instructions of the manu-
facturer. Sections were mounted in Vectashield fluores-
cence mounting media (Vector Laboratories, Burlingame,
CA, USA), and images were acquired on a Zeiss 710 con-
focal microscope (Carl Zeiss, Jena, Germany) with a pinhole
aperture of 1 airy unit.
Indirect immunofluorescence
Fixed #3 mammary glands were processed and embedded in
paraffin wax. Paraffin sections of 5 μm were prepared and
subjected to 1 mM disodium-ethylenediaminetetraacetic
acid (EDTA) antigen retrieval as described previously [21].
Primary antibodies used for immunofluorescence are
the following: cytokeratin-8 (CK8) (TROMA-I, rat, 1:100;
Developmental Studies Hybridoma Bank, Iowa City, IA,
USA), estrogen receptor (NCL-ER-6 F11, mouse, 1:100;
Novocastra, which is part of Leica, Wetzlar, Germany),
GFP (600-401-215, rabbit, 1:100; Rockland Immunochemi-
cals Inc., Gilbertsville, PA, USA), GFP (600-141-215, goat
coupled to Dylight-488, 1:300; Rockland Immunochemicals
Inc.), progesterone receptor (MAB9785, rabbit, 1:400;
Abnova, Taipei, Taiwan), and smooth muscle actin (SMA)
(A2547, mouse, 1:1,000; Sigma-Aldrich, St. Louis, MO,
USA). Secondary antibodies used at 1:400 dilution are
from Invitrogen Corporation: Alexa488-coupled goat
anti-mouse (A11029), Alexa488-coupled goat anti-rabbit
(A11034), Alexa568-coupled goat anti-mouse (A11031),
and Alexa568-coupled goat anti-rabbit (A11036). Add-
itionally, CF633nm-coupled donkey anti-rat (20137–1;
Biotium, Hayward, CA, USA) was used at 1:400 dilution.
Isolation of primary mammary epithelial cells for
fluorescence-activated cell sorting, RNA, and genomic
DNA
Abdominal and inguinal glands were pooled and processed
either for single mammary epithelial cell isolation for FACS
analysis as previously described [21] or else processed justto the organoid stage for purposes of harvesting RNA and
genomic DNA. At this point, three quarters of the orga-
noid suspension was pelleted for lysis in PureZOL RNA
isolation reagent (Bio-Rad Laboratories, Inc., Hercules,
CA, USA), and total RNA then was prepared in accord-
ance with the instructions of the manufacturer. The
remaining quarter was pelleted and resuspended in 0.1 M
Tris-Cl pH 8/0.2 M NaCl/5 mM EDTA/0.2% SDS/0.2 mg/
mL Proteinase K for overnight digestion at 50°C. Genomic
DNA was precipitated out from the digest with 1 volume
isopranol, washed in 70% ethanol, and resuspended in
100 μL of water. A hundred nanograms of genomic DNA
was amplified per sample, 35 cycles with Taq polymerase
(Fermentas, Vilnius, Lithuania).
Cell labeling, flow cytometric analysis, and
fluorescence-activated cell sorting
Fluorochrome-conjugated antibodies were titrated on pri-
mary mammary epithelial cells to ensure maximal positive
signal-to-background fluorescence ratio. Anti-mouse or
anti-rat compensation beads (BD 552843 and 552845,
respectively) or both were used for single-stain antibody
controls. Compensation controls also included two
cellular samples: unstained cells and cells stained with
4′,6-diamidino-2-phenylindole (DAPI) (D8417; Sigma-
Aldrich). Cells were incubated with antibodies on ice for
45 minutes with agitation every 15 minutes. Samples were
then washed with twice the sample volume and resus-
pended in L15 (Gibco-Life Technologies, now part of
Invitrogen Corporation) with 6% fetal calf serum (FCS)
(HyClone, Logan, UT, USA) and 200 ng/mL of DAPI,
except non-DAPI compensation controls. All multiple-
labeled samples were gated on FSC-A versus SSC-A and
doublet discrimination (FSC-H versus FSC-W and SSC-H
versus SSC-W) and DAPI negativity. Samples contained
anti-CD45 to exclude lymphocytes from analysis. Cells
were analyzed and sorted on a BD FACS-Aria II contain-
ing 355 nm UV, 488 nm blue, 561 nm yellow-green, and
633 nm red lasers (BD Biosciences, San Jose, CA, USA).
Specific antibodies used and gating strategy are detailed in
Additional file 1.
Synthesis of cDNA and quantitative polymerase chain
reaction analysis
For analysis of transcript levels by quantitative polymer-
ase chain reaction (qPCR) in FACS-sorted populations,
cells were sorted directly into lysis buffer (10 IU RNase
inhibitor (Invitrogen Corporation), 2 mM dithiothreitol
(DTT), 0.15% Tween-20 (Bio-Rad Laboratories, Inc.) in
12 μL of nuclease-free water) in PCR tubes by using a
direct reverse transcription (RT) method described by
Ho and colleagues [25]. Five hundred cells were sorted
into each tube, and RT was performed by using Super-
script VILO (Invitrogen Corporation) in accordance with
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PureZOL-purified total RNA harvested from epithelial
organoids, cDNA was prepared by using the Bio-Rad
iSelect kit (Bio-Rad Laboratories, Inc.) and a pool of
gene specific RT primers (each at 0.42 mM final concen-
tration), comprising the reverse primers for each of the
amplified genes: WAP, Cre transgene, YFP transgene,
Elf5, and hypoxanthine-guanine phosphoribosyltransfer-
ase (HPRT). Primers were designed that span introns to
exclude the detection of genomic DNA and selected for
optimum melt curve and amplification profiles. The
primers to detect the WAP-Cre transgene expression were
designed from the Cre sequence and rabbit β-globin polyA
sequence which spans the β-globin intron that is spliced
out in MECs (data not shown). All primer sequences are
listed in Additional file 2. In the case of the intronless YFP
transcript, a no-reverse-transcriptase (NRT) control reac-
tion was run in parallel with the normal RT reaction, and
qPCR background signal from the NRT reaction (due to
genomic DNA contamination in those samples with low
RNA yields) was subtracted from the RT reaction quanti-
fication for YFP in the reported results. qPCR was per-
formed by using Sso Fast Evagreen supermix reagent
(Bio-Rad Laboratories, Inc.) in accordance with the proto-
col of the manufacturer. To assess genomic recombination
of the Rosa-lsl-YFP locus, primer sequences flanking the
loxP sites were designed such that the recombined locus
could be amplified from organoid genomic DNA as a 578-
bp band (Additional file 3), whereas the unrecombined
locus would generate a 3,244-bp band (data not shown).
Results
Genetic labeling of parity-identified mammary epithelial cells
To investigate the cellular identity and lineage potential
of PI-MECs in intact mammary glands, we chose to label
them with a fluorescent reporter. The labeling of PI-MECs
was first described by Wagner and colleagues [15,23] andFigure 1 Labeling of parity-identified mammary epithelial cells (PI-ME
protein (YFP) is not expressed (white cell) until the whey acidic protein (WAP) p
results in the expression of sufficient levels of the Cre recombinase, the loxP site
excised (dotted line), bringing the YFP gene under control of the constitutive
cells will remain YFP-positive even though WAP is not expressed (green cell, WAPmakes use of the Cre/lox system to permanently label
cells by genetic recombination. They created a transgenic
mouse line expressing the Cre recombinase under the
control of the WAP gene promoter [23]. We crossed these
with a reporter strain that contains the YFP gene sepa-
rated from the constitutive Rosa26 promoter by a stop se-
quence flanked by loxP sites (Rosa26-lox-stop-lox-YFP, or
Rosa-lsl-YFP) [24]. Transcriptional activation of the WAP
promoter induces expression of Cre recombinase [16],
which excises the transcriptional stop sequence in the re-
porter construct under control of the constitutively active
Rosa26 promoter (Figure 1). From that point onwards, the
cell and all of its progeny permanently express the YFP re-
porter gene.
We crossed WAP-Cre mice with the Rosa-lsl-YFP strain
and collected mammary glands from double transgenic
female mice before, during, and after pregnancy (Figure 2).
Thoracic mammary glands were examined by whole-
mount fluorescence microscopy (Additional file 4) and by
cryosections (Figure 2) to confirm the proper functioning
of the PI-MEC labeling system. The cryosections were
counterstained with phalloidin to visualize the alveolar
structures independent of their YFP status. At day 7 of the
first pregnancy, we detected no evident YFP expression by
wholemount analysis (Additional file 4A) and very few
YFP-positive (YFPpos) cells on cryosections (Figure 2A, see
Additional file 5 for close-ups of individual cells). In only
one mouse out of five harvested at this stage did we ob-
serve extensive YFP labeling of epithelial structures (later
determined by FACS to represent approximately 6% of
epithelial cells; Additional file 6), which may be attribut-
able to minor alveolar development as part of normal
estrus cycling, as previously described [15]. At 14 days
of pregnancy, we detected unambiguous activation of
the YFP reporter gene (Figure 2B), with about half of
alveoli containing at least one YFP-expressing cell and
a small percentage of alveoli consisting of more thanCs). In WAP-Cre;Rosa26-lsl-YFP double transgenic mice, yellow fluorescent
romoter is induced (by pregnancy). When activation of the WAP promoter
s (triangles) will be recombined and the sequence in between will be
ly active Rosa26 promoter (green cell, WAP on). Upon cell division, daughter
off) as a result of the genetic deletion of the stop sequence.
B C DA
E GF
Figure 2 Analysis of parity-identified mammary epithelial cells (PI-MECs) during first and second pregnancies. Mammary glands from
WAP-Cre; Rosa-lsl-YFP mice were collected at the following stages: 7 days (A) and 14 days (B) of the first pregnancy, 3 days of lactation (C),
involuted (>6 weeks after weaning) (D), and 7 days (E) and 14 days (F) of the second pregnancy. Cryosections were analyzed for YFP expression
(green) and counterstained with rhodamine-conjugated phalloidin (red). Representative confocal microscope images were captured with 20×
(upper panels) and 63× (lower panels) objective lenses. Bar is 50 μm. White arrowhead indicates a PI-MEC (YFPpos cell that survived involution),
and the yellow arrows indicate collapsed YFP bodies seen often in involuted sections. (G) Quantification of relative mRNA levels in mammary
epithelial organoid isolates. Gene expression is normalized to hypoxanthine-guanine phosphoribosyltransferase (HPRT) expression, and error bars
indicate standard deviation of three individual mice at each time point.
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ing using the LacZ reporter, which was undetectable at
14 days and started at only 15 days [11] or 18 days of
pregnancy [15]. This could be due to more efficient
floxing of the YFP reporter compared with the LacZ
reporter or a difference in the sensitivity of detection
of the labeled cells. We could detect WAP mRNA, and
in parallel Cre mRNA, in primary MEC preparations at
day 7 of the first pregnancy (Figure 2G). Consistent
with the observed Cre expression and appearance of
more YFPpos cells, we could detect recombination ofthe genomic Rosa26 locus by PCR at pregnancy day 7
(Additional file 3) which is followed at day 14 by de-
tectable accumulation of mRNA expression for YFP
(Figure 2G). As expected, WAP (and Cre) expression
reached maximum levels during lactation. Expression
of the alveolar specification gene Elf5 [26] reflects the
increase in the number of alveolar cells generated dur-
ing pregnancy and precedes the appearance of YFP,
which is dependent on the accumulation of sufficiently
high levels of the Cre recombinase in the individual
cells (Figure 2G).
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only YFP-expressing cells (Figure 2C, see also Additional
file 5C), consistent with complete recombination of the
Rosa-lsl-YFP locus at this stage and underscoring the effi-
ciency of the WAP-Cre/YFP labeling system. Larger ducts
of glands at 3 days lactation often remained negative for
YFP, in contrast to secondary ducts or side branches that
contain multiple YFPpos cells (Figure 2C, top panel and
Additional file 7). Six weeks after weaning, the alveolar
structures had been cleared by involution. Only the ductal
network and regressed terminal branches remained in
the post-involution glands, and YFPpos cells were readily
detectable in involuted mammary epithelium (Figure 2D).
These YFPpos cells are referred to as PI-MECs, cells present
in parous tissue that survived involution. In contrast, a
large proportion of cells that were initially labeled during
pregnancy terminally differentiated and were removed.
Thus, not all YFPpos cells that are present during preg-
nancy and lactation will become PI-MECs. In parous epi-
thelium, WAP and Cre expression dropped by several
orders of magnitude, consistent with loss of detectable
WAP protein at this stage [19]. Notably, the baseline WAP
mRNA expression remains higher after involution than in
virgin mice (Figure 2G), consistent with a recent study
from the Bentires-Alj laboratory [27]. Overall, these results
were concordant with observations with previously pub-
lished LacZ and GFP reporters [11,15,22,23,28].
At day 7 of the second pregnancy, alveoli emerged from
the involuted ductal network. In contrast to the first
pregnancy, some of these contained mostly YFPpos cells,
whereas others were unlabeled (Figure 2E). The majority
of these YFPpos cells are likely progeny generated by PI-
MECs (this will be addressed later). By day 14 of the sec-
ond pregnancy, most alveoli were completely labeled by
YFP (Figure 2F) but with a marked proportion of alveoli
that were still partially labeled or even unlabeled. This
suggests that, in addition to PI-MEC-derived alveoli
which are already YFP-labeled, some alveoli were de-
rived from unlabeled progenitors that progressively
undergo YFP recombination and activation, perhaps at
a somewhat accelerated pace compared with the first
pregnancy (compare Figure 2B and F). The increase in
cells with a de novo recombined YFP reporter coin-
cides with the renewed induction of WAP (and in par-
allel Cre) during the second pregnancy (Figure 2G,
note the logarithmic scale).
Parity-identified mammary epithelial cells are luminal
cells that express markers of alveolar progenitor cells
After validation of the reporter system, we set out to
characterize the cellular identity of PI-MECs by FACS
analysis by using cell surface markers for the various epi-
thelial populations of the mammary gland. Six weeks
after weaning, involuted mammary glands were processedto single cells, and luminal and basal MEC populations were
identified by staining for CD24 and α6-integrin (CD49f)
[21,29], after exclusion of doublets, dead cells, and lympho-
cytes (Figure 3A and Additional file 1B). Analysis of four
individual WAP-cre;Rosa-lsl-YFP animals showed that the
YFPpos cells (PI-MECs) fall squarely within the luminal
gate (Figure 3B). Plotting the luminal and basal population
on separate histograms for YFP further highlights the lack
of PI-MECs in the basal population (Figure 3C). Within
the luminal population, PI-MECs represent roughly half
of the population (Figure 3C and D). Immunofluorescence
staining on sections of involuted mammary glands con-
firmed the exclusive localization of PI-MECs to the
luminal layer (Figure 3E and F). Cells identified with an
antibody recognizing YFP also expressed the luminal cell-
specific marker CK8 but never the basal cell-specific
marker SMA. In contrast to the previously reported basal
identity of cultured PI-MECs [22], these data definitively
establish PI-MECs as a luminal cell type in intact mam-
mary glands.
To further evaluate the cellular identity of PI-MECs
within the luminal population, we separated the luminal
cells into hormone-sensing cells (Sca1hiCD49blo) and
estrogen receptor (ER)-negative cells (Sca1loCD49bhi)
[21,29] (Figure 4A). The ER-negative Sca1loCD49bhi
population contains most of the progenitor activity in
the luminal population as measured by colony-forming
ability [29] and likely contains progenitor cells in dif-
ferent stages of lineage commitment. For clarity, and
based on our results described below and the enrich-
ment for markers such as beta-casein and Elf5 [21,30],
we refer to the ER-negative Sca1loCD49bhi population
as ‘alveolar progenitor cells’.
FACS analysis of MECs isolated from involuted mam-
mary glands and stained for Sca1 and CD49b showed
that about a quarter of luminal cells fell within the gate
for hormone-sensing cells, whereas the remaining three
quarters were found within the alveolar progenitor gate
(Figure 4B). YFP-negative (YFPneg) cells belonged to both
cell types, but the vast majority of YFPpos cells were part
of the alveolar progenitor population (Figure 4C). Only
around 6% of YFPpos cells were part of the hormone-
sensing cell population (Figure 4D). This rare population
expresses ERα mRNA to the same extent as the collective
hormone-sensing cell population (Additional file 8),
suggesting that their FACS profile truly reflects a hormone-
sensing identity of these cells. Notably, even though al-
most all YFPpos cells belonged to the alveolar progenitor
population, about 40% of the alveolar progenitor popula-
tion in the involuted mammary gland lacked YFP expres-
sion (Figure 4D). Since secretory alveoli were close to
100% YFPpos at lactation (Figure 2C), this YFPneg popula-
tion may represent alveolar progenitors that resided in the








































Figure 3 Parity-identified mammary epithelial cells (PI-MECs) in involuted mammary glands are luminal. (A) Epithelial cells isolated from
involuted mammary glands were labeled with fluorescent antibodies against CD24 and α6-integrin (CD49f) to distinguish the luminal (blue gate)
and basal (red gate) population. (B) Yellow fluorescent protein-negative (YFPneg) cells and YFPpos cells (PI-MECs) are shown separately on density/
contour plots. (C) The luminal and basal populations are plotted in separate histograms to quantify the proportion of YFP-positive cells in each
population (D); error bars indicate standard deviation for 4 individual mice. (E) Immunofluorescent probing of involuted mammary epithelium for
YFP (PI-MECs, green), the luminal marker cytokeratin-8 (CK8) (blue), and basal marker smooth muscle actin (SMA) (red). Nuclei are labeled by
4′,6-diamidino-2-phenylindole (DAPI) (grey). (F) Omission of the YFP signal from the image shown in (E) shows the mutual exclusive labeling of
luminal cells by CK8 (blue) and basal cells by SMA (red). Bar is 10 μm.
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be three major populations of luminal cells in involuted
mammary epithelium: (a) YFPneg hormone-sensing cells,
(b) YFPneg alveolar progenitor cells, and (c) YFPpos alveo-
lar progenitor cells (PI-MECs). Immunofluorescence ana-
lysis on tissue sections confirmed the presence of all of
these three types of cells and showed their juxtaposition
within the luminal layer of ducts in involuted mammary
glands (Figure 4E).
We have optimized a direct lysis method for qPCR ana-
lysis of limited numbers of cells [25] and used this method
to validate the molecular identity of the cell populations
identified by FACS. Estrogen receptor alpha (ERα) and
progesterone receptor (PR) expression was largely limited
to hormone-sensing cells (Figure 4F), whereas both YFPpos
and YFPneg alveolar progenitor populations exclusively
expressed the alveolar marker genes Elf5 and β-Casein
[26] (Figure 4G). PI-MECs thus clearly belong to the
luminal alveolar lineage within the involuted mammary
epithelium.Initially, we performed a microarray on YFPpos and
YFPneg luminal cells in order to identify unique cell sur-
face markers of PI-MECs to facilitate future studies of this
cell population without the need for generating parous
double transgenic mice. However, the presence of a signifi-
cant proportion of YFPneg alveolar progenitor cells that ex-
press Elf5 and β-casein to the same extent as the YFPpos
cells explains why we were unable to identify unique
markers for PI-MECs. Apart from YFP, which was enriched
approximately 30-fold and validates the sorting procedure,
no other transcripts were significantly enriched in the
YFPpos population (data not shown). This suggests that the
YFPpos and YFPneg alveolar progenitor populations share
their transcriptome profile beyond Elf5 and β-Casein.
Taken together, our data show that in involuted mammary
epithelium apart from PI-MECs there exists an unlabeled al-
veolar progenitor population with a similar transcriptional
and cell surface profile. To address the question of
whether this unlabeled alveolar progenitor population is
functionally equivalent to PI-MECs, we examined the
Figure 4 Parity-identified mammary epithelial cells (PI-MECs) in involuted mammary glands belong to the alveolar progenitor
population. (A) The luminal population of mammary epithelial cells (CD24hi CD49flo) is separated into hormone-sensing cells (Sca1hi CD49blo;
purple gate) and alveolar progenitor cells (Sca1lo CD49bhi; orange gate). (B) Relative proportions of hormone-sensing (HS) cells and alveolar
progenitor cells (Alv) within the luminal population. (C) Analysis of yellow fluorescent protein-negative (YFPneg) (grey) and YFPpos (PI-MEC, green)
subpopulations of luminal cells shows that PI-MECs are found mainly in the alveolar progenitor cell population (orange gate). Note that the
combined density/contour plot shows the relative distribution of the population on display and therefore the HS population appears larger in
(C) than in (A) because the YFPpos population is plotted separately in (C). (D) Distribution of YFPneg cells and YFPpos PI-MECs within populations
of HS cells (Sca1hi CD49blo; purple label) and of alveolar progenitor cells (Sca1lo CD49bhi; orange label). (E) Immunofluorescent probing of an
involuted mammary section identifies three luminal cell types: HS cells expressing the estrogen receptor alpha (ERα) (red), PI-MECs expressing YFP
(green), and luminal cells expressing CK8 (blue) but neither ER nor YFP. Bar is 10 μm. (F) Relative mRNA expression levels of HS cell marker genes ERα
and progesterone receptor (PR) and (G) alveolar cell marker genes Elf5 and β-Casein on populations of sorted HS cells (Sca1hiCD49blo) or alveolar
progenitor cells (Sca1loCD49bhi) which were separated based on their YFP expression. Error bars indicate standard deviation for four individual mice.
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veologenesis in a second pregnancy (Figure 5).
An unlabeled pool of alveolar progenitor cells is
equipotent to parity-identified mammary epithelial cells
To evaluate whether PI-MECs or the unlabeled alveolar
progenitor cells were the main source for the develop-
ment of new alveoli, we analyzed WAP-Cre;Rosa-lsl-YFP
females at day 7 of their second pregnancy. In typical
lineage-tracing techniques, Cre is activated for a short time
period following administration of a chemical inducer [31].
In contrast in PI-MEC labeling, Cre expression iscontrolled by WAP promoter activity and therefore the
progeny of PI-MECs can be traced only during devel-
opmental time periods when WAP is not expressed.
We chose the 7-day second pregnancy time point be-
cause alveologenesis is already apparent but WAP ex-
pression is not significantly induced yet ([15,16] and
Figure 2G). Thus, YFPpos alveoli at this time point
likely originate from PI-MECs and are not the result of
de novo activation of the reporter, which occurs again
later in the second pregnancy (Figure 2F).
In involuted glands, roughly half of the alveolar pro-
genitor population was YFPpos (Figure 4D). Strikingly, at
Figure 5 A large proportion of alveoli derive from non-parity-identified mammary epithelial cells (non-PI-MECs) during the second
pregnancy. (A-C) Cryosections stained with phalloidin (red) of three independent mice used to quantify the relative contribution of PI-MECs to
alveolar development at day 7 of the second pregnancy. Scale bar is 50 μm. (D) The vast majority of alveoli were scored as either completely
yellow fluorescent protein (YFP)-negative (grey) or completely YFP-positive (green), with few alveoli containing a mixture of the two, as
highlighted by the red box. (E) Quantification of the YFP pattern in alveoli of three mice (X-Z) at day 14 of the first pregnancy (a time of de novo
floxing). At least 750 alveoli/mouse were counted.
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stained for YFP either almost completely or not at all
(Figure 2E and Figure 5A-C, more examples in Additional
file 9). Therefore, besides the PI-MECs that give rise to
YFPpos alveoli, there is a significant contribution of un-
labeled cells that can form morphologically indistinguishable
alveoli. Notably, the number of alveoli derived from PI-
MECs or unlabeled alveolar progenitor cells varied widely
between animals. To quantify this effect, a cryosection of
an entire mammary gland from each of the three mice
was scanned on a confocal microscope and reconstituted
digitally (see Additional file 10 for an example). Each indi-
vidual alveolus from a section was then scored into one of
three categories: YFPneg, YFPpos, or partially labeled by
YFP. To be considered YFPpos, at least 90% of the cells in
the alveolus must express YFP, since we had noticed that
alveoli frequently contain a few ER-positive hormone-
sensing cells which are YFPneg (Figure 6). In all three
7-day pregnant samples, the vast majority of alveoli
were scored as either YFPpos or YFPneg (Figure 5A-D
and Additional file 11). This all-or-nothing distribution
suggests a clonal contribution from either an unlabeled al-
veolar progenitor or a PI-MEC rather than a mixture ofalveolar progenitors contributing to the same alveolus.
The small proportion of alveoli that had a mixture of
YFPpos and YFPneg cells could signify the mixed contribu-
tion of a labeled and an unlabeled progenitor, but these
partially labeled alveoli could also reflect early de novo ac-
tivation of the reporter. Indeed, reporter activation due to
induction of WAP expression at 14 days of the first preg-
nancy shows a similar stochastic pattern and the majority
of alveoli that become labeled at this point belong to the
YFPpartial category (Figure 5E and Additional file 11). To-
gether with the radically different ratio of partial-versus-
totally labeled alveoli (1:3 at day 7 of the second pregnancy
compared with 5:1 at day 14 of the first pregnancy),
these data fit best with a model whereby at day 7 of
the second pregnancy the frequency of de novo floxing
is still low and the majority of YFPpos cells are gener-
ated by PI-MECs.
Overall, the relative contribution of PI-MECs to alveolo-
genesis, as measured by the fraction of total YFPpos alveoli,
varied from 4% to 79%. A similar variation was found
when four independent animals were analyzed by FACS
(27% to 77%, Figure 6H). It is currently unclear whether
this variation is stochastic or whether certain conditions
Figure 6 Parity-identified mammary epithelial cells (PI-MECs) remain lineage-restricted during pregnancy. (A) Immunofluorescence on
paraffin sections from the 7-day second pregnancy time point, showing alveoli in which all cells are yellow fluorescent protein-positive (YFPpos),
except for rare luminal cells expressing estrogen receptor alpha (ERα) (red, yellow arrows) or basal (CK8-negative, white arrowhead) cells.
(B) Alveolar clusters at day 14 of the first pregnancy that already consist mostly of YFPpos cells also contain hormone-sensing (HS) cells
(labeled by an antibody against the progesterone receptor, red) which do not express YFP. Scale bar is 10 μm. (C) Mammary epithelial cells from
7-day pregnant glands (second pregnancy) labeled with CD24 and CD49f to segregate luminal (blue gate) from basal (red gate) single-cell populations.
(D) YFPneg cells and YFPpos cells (PI-MECs) are shown separately on density/contour plots for CD24 and CD49f. (E) Sca1 and CD49b plots of the luminal
cell population at 7 days of pregnancy, showing the HS cell population (purple gate) and alveolar cells (orange gate). (F) Distribution of YFPneg cells
and YFPpos PI-MECs within populations of HS cells and of alveolar cells. Note that the combined density/contour plot shows the relative distribution of
the population on display and therefore the HS population appears larger in (D) than in (C) because the YFPpos population is plotted separately in (D).
(G) Distribution of YFPpos cells across the different populations. Inset: magnified basal and HS cell bars. (H) Percentage of YFPpos cells observed within
the basal, HS, and alveolar cell populations. Error bars indicate standard deviation of four independent mice. (I) A small percentage of ER+ cells are also
YFPpos (arrowhead), although most HS cells are YFPneg (arrow). Scale bar is 10 μm.
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however, that the females in Figure 5A and B, which show
the most divergence in PI-MEC contribution, are litter-
mates who shared nearly identical histories. The propor-
tion of YFPpos alveoli was roughly similar in the right and
left mammary glands of each individual mouse (data not
shown). This suggests that the relative contribution of PI-
MECs and unlabeled alveolar progenitors to alveologenesis
is due to systemic regulation rather than independent
gland-autonomous effects.
In summary, even though PI-MECs contribute signifi-
cantly to the generation of new alveoli, a substantial propor-
tion of newly developing alveoli are unlabeled. Therefore,
the unlabeled alveolar progenitor cells that are present after
involution not only are very similar to PI-MECs in their
transcriptome and cell surface markers but also have the
ability to contribute to alveologenesis to the same extent
as PI-MECs.
Basal and hormone-sensing cells of developing alveoli are
not generated by parity-identified mammary epithelial cells
At low magnification, clusters of alveoli appeared to be
clonally derived from PI-MECs (for example, Figure 5B
and Additional file 9); however, at a higher magnification,
it became apparent that even though the majority of cells
in these alveoli were YFPpos, they consistently contained a
small fraction of YFPneg cells. To investigate the cellular
identity of these YFPneg cells, we stained paraffin sections
with antibodies against YFP, ER, and CK8. Figure 6A
shows a typical example from the 7-day second pregnancy
time point, whereby all luminal cells in an alveolus are
YFPpos, except the few cells that express the ER (in
red) (more examples in Additional file 12). CK8-negative
basal cells are also YFPneg, like hormone-sensing cells
(Figure 6A). The small proportion of alveoli that are al-
most fully recombined at 14 days of the first pregnancy
also contain a low proportion of YFPneg cells (Figure 6B).
We noted that the signal intensity for ER is already re-
duced by 7 days of pregnancy and becomes virtually un-
detectable at 14 days, and therefore we used an antibody
against progesterone receptor for sections from 14-day
pregnant animals. Again, the majority of YFPneg cells
are hormone-sensing cells (Figure 6B), similar to the
7-day second pregnancy time point (Figure 6A). Thus,
even though all luminal alveolar cells derive from a com-
mon progenitor cell (based on the clonal appearance at
7 days of the second pregnancy), developing alveoli contain
cells from different lineages; PI-MECs are able to contrib-
ute all ER-negative luminal cells to a cluster of alveoli, but
the hormone-sensing and basal cells are derived from dif-
ferent lineages (see Figure 7 for a schematic representation
of these observations).
Since PI-MECs can give rise to all mammary epithelial
cell types in transplantation experiments [11,15,22], wefurther evaluated their lineage potential in vivo during a
normal pregnancy by FACS analysis (Figure 6C). Separat-
ing the mammary epithelial population of WAP-Cre;Rosa-
lsl-YFP mice at 7 days of the second pregnancy into YFPneg
and YFPpos subpopulations showed that the majority of
YFPpos cells remained restricted to the luminal cell popula-
tion (Figure 6D). Only 0.29% ± 0.03% of PI-MEC-derived
cells were found in the basal cell compartment, indicating
that PI-MECs cannot be the source of the expansion of
the basal layer during pregnancy. A closer examination of
the luminal subpopulations showed that during pregnancy
the hormone-sensing cells lose their CD49b and especially
their Sca1 expression (Figure 6E versus Figure 4A), con-
sistent with a previous report [29]. The cellular identity of
the FACS populations was again validated by qPCR. Even
during pregnancy, more than 98% of PI-MECs remained
firmly within the luminal alveolar progenitor population
(Figure 6F and G). These data show that, as a rule, PI-
MECs remain restricted to the luminal alveolar lineage
during pregnancy and do not contribute significantly to
the other lineages.
Out of all the hormone-sensing cells analyzed by FACS
at the 7-day second pregnancy time point, only 1.7% ±
1.2% were YFPpos (Figure 6H). Even though the percentage
of YFPpos cells in the hormone-sensing cell gate was small,
it is not noise in the FACS data, because rare cells that
were positive for both ER and YFP were detectable by
confocal microscopy of tissue sections from pregnant
mice (Figure 6I).
Taking these findings as a whole, we conclude that, in
contrast to the clear multi-lineage potential of PI-MECs
in transplantation assays, the lineage potential of PI-
MECs in vivo is almost entirely restricted to luminal ER-
negative cells, even during pregnancy.
Discussion
Parity-identified mammary epithelial cells are restricted
luminal estrogen receptor-negative progenitors
We show that PI-MECs are a strictly luminal population,
both by FACS analysis (including qPCR validation of the
different populations) and by confocal microscopy on
tissue sections from primiparous and pregnant mice.
Matulka and colleagues [22] reported that PI-MECs
were located at the tip of the basal cloud, the same pos-
ition as the mammary stem cells. They used a GFP re-
porter strain to label the PI-MECs and made use of the
same cell surface markers (CD24 and CD49f), but an
important difference is that the cells were cultured for 3
days before FACS analysis. Based on the reproducibility
of our results in all animals examined and the agreement
between different methods, we conclude that PI-MECs
are a luminal cell type.
In line with the labeling based on expression of one of the
milk genes (WAP), we found that PI-MECs have an alveolar
Figure 7 PI-MEC lineage tracing (A) and a stem cell hierarchy for intact mammary glands (B). (A) The YFP reporter becomes robustly
activated by 14 days of the first pregnancy (green) and by lactation virtually all secretory cells are labeled. After involution, labeled cells are
present in the luminal layer of the ducts (only stage where PI-MECs can be definitively recognized, black diamond). At 7 days of the second
pregnancy, PI-MECs give rise to all of the ER-negative luminal cells of some but not all alveoli (WAP promoter activity is low at this stage).
PI-MECs do not generate the alveolar basal cells (red) and ER+ cells (purple). By 14 days of the second pregnancy, the WAP promoter is
significantly induced, and ER-negative luminal cells in alveoli become labeled de novo. ER expression becomes more difficult to detect (grey), but
the hormone-sensing cells still express PR and not YFP (see Figure 6). (B) Bipotent stem cell activity was reported during embryonic development
and puberty [10,34]. In adult non-pregnant mammary glands, unipotent cells maintain the luminal and basal layer [10,34]. We show that PI-MECs
are located in the luminal layer and belong to the alveolar lineage (orange). This lineage also contains a population of unlabeled cells with a
similar cell surface and gene expression profile. A small proportion of ER+ cells is also YFPpos (< 6%) but it is unclear whether this is due to
lineage plasticity or a technical artifact. During pregnancy, a significant proportion of alveoli is formed by cooperative outgrowth of ER-negative
luminal cells , hormone-sensing cells and basal cells (7B-1, see Figure 6 and Discussion). An unknown proportion of alveoli contain luminal
and basal cells derived from the same Axin2-traced basal progenitor [34] (7B-2), it remains to be tested if this progenitor also generates
hormone-sensing cells.
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and gene expression (Elf5, β-casein). Consistent with pre-
vious reports, PI-MECs contribute significantly to alveolar
development in pregnancy, and we therefore designate
them luminal alveolar progenitor cells.
Unexpectedly, we noted that, at least in primiparous
mice, there is a population of YFPneg alveolar progenitor
cells that displays characteristics similar to those of PI-
MECs. Possibly, these cells resided in the larger ducts dur-
ing lactation where hardly any cells were YFP-labeled, in
contrast to the almost complete labeling of the secretory
cells in the alveoli (Additional file 7). Interestingly, there
seemed to be a gradient of reporter activation in the ducts
because we detected quite a number of YFPpos cells in the
smaller ducts of lactating glands. This raises the question
of whether PI-MECs might be part of an alveolar pro-
genitor reservoir that is located in the ducts rather
than representing fully committed secretory cells that
dedifferentiated and reintegrated into the ducts during
involution, but a different experimental system is re-
quired to address this.
The use of the WAP promoter to label PI-MECs creates
a technical challenge to investigate PI-MEC progeny, be-
cause new YFPpos cells could be either daughter cells of
PI-MECs or the result of activation of the WAP promoter.
Even though we found a general increase in baseline activ-
ity of the WAP promoter in parous MECs (similar to [27])
and in early pregnancy, our data indicated that de novo
floxing activity was low at day 7 of the second pregnancy
and we used this time point to analyze the lineage po-
tential of PI-MECs. We used both FACS and confocal
microscopy to analyze the progeny generated by the YFP-
labeled alveolar progenitors in early pregnancy and found
that PI-MECs can produce all the steroid receptor-
negative luminal cells of an alveolus; however, as a rule,
they do not generate basal or hormone-sensing cells of
alveoli (Figure 7A). The more restricted lineage po-
tential observed in recent lineage-tracing strategies
based on intact mammary glands compared with previ-
ous transplantation studies has prompted the revision of
current models of the mammary stem cell hierarchy
[10,32]. Previously, PI-MECs have been designated (lim-
ited) stem cells based on their contribution to multiple
lineages in cleared fat pad transplantations [11,14,32]. The
data presented here warrant a revision of the place of PI-
MECs in the hierarchy: strictly into the luminal lineage
(Figure 7B). Note that our observation that PI-MECs
generate luminal but not basal cells is consistent with
a study showing that in intact mammary glands basal
cells maintain the basal layer and luminal cells maintain
the luminal layer [10].
Even though it is clear that PI-MECs are remarkably
restricted to the luminal alveolar lineage, we observed a
small percentage of labeled cells that belonged to theluminal ER+ population by FACS and in tissue sections of
early pregnancy. It remains to be determined whether
this reflects a low level of plasticity of PI-MECs in situ
(Figure 7B) or whether hormone-sensing cells induce WAP
expression in particular circumstances. Interestingly, the
multipotency of PI-MECs in reconstitution assays suggests
that the conditions of transplantation can unlock their
lineage restriction. However, cells from the basal layer have
the most robust long-term multipotent potential in trans-
plantation assays [9,33], whereas the reconstitution poten-
tial of PI-MECs or luminal populations identified by other
methods is more limited [11,33], suggesting that some
lineage restriction remains even in transplantation as-
says. It will be interesting to investigate what factors
control the lineage potential of these different cell
populations both in intact mammary glands and in
reconstitution assays and to what extent transplant
conditions reflect circumstances relevant for tumori-
genesis and metastasis.Alveoli are formed by collaborating cell types
An alternative version of the mammary stem cell hier-
archy has been proposed on the basis of transplantation
experiments that show ductal-limited and lobule-limited
mammary epithelial outgrowths [3]. Instead of a division
into a basal and a luminal lineage as discussed above
[32], this alternative model proposes that stem cells give
rise to a ductal- and lobule-restricted lineage whereby
the lobule-restricted progenitors are thought to give rise
to both the basal and luminal cells of alveoli [6,13]. We
did not detect the activity of a bipotent lobule-restricted
progenitor, because we did not observe any YFPpos basal
cells by histology, and less than 0.1% of basal cells were
YFPpos by FACS analysis and could be technical noise.
Consistent with our observation that the basal cells in
alveoli are derived from a different source are recent
lineage-tracing experiments with the Axin2-promoter
whereby Cre-ER was activated briefly before puberty. In
those experiments, clonal Axin2-traced offspring con-
tributed exclusively to the basal layer of multiple clusters
of alveoli [34]. In contrast, when Cre activity was briefly
induced in adult females, the authors found evidence
that Axin2-traced progeny could contribute to both the
luminal and basal layers of alveoli [34] (Figure 7B). Inter-
estingly, after involution, Axin2-traced cells remained in
the luminal layer, suggesting that PI-MECs could poten-
tially be generated from Axin2-traced basal cells. The
Axin2-lineage tracing experiments demonstrate that bipo-
tent activity can be detected in intact mammary glands of
adult mice; however, it is unclear how common this activ-
ity is. Our data show that PI-MECs make a significant,
though variable, contribution to alveologenesis, but this
does not include basal alveolar cells.
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minal ER-positive cells, even when all ER-negative luminal
cells of an alveolus are derived from PI-MECs. Interest-
ingly, lineage-tracing of cells that expressed Notch2 in
puberty revealed two previously unrecognized cell types—
small string cells and large L cells—and these cell types do
not fit in current models of the stem cell hierarchy [35].
The cells from the Notch2-lineage are functionally re-
quired for alveologenesis, and the authors showed that
each alveolus contains a small proportion of L cells. An
inverse picture of what we have observed was found in
Notch2-lineage tracing experiments in early pregnancy:
alveoli in which only a single L cell is labeled and the
remaining luminal alveolar cells are unlabeled and thus
derived from a different source [35]. In addition, hormone-
sensing cells play an important role in the early stages of
alveologenesis due to their secretion of paracrine factors
such as receptor activator of nuclear factor kappa-B ligand
(RANKL) and insulin-like growth factor 2 (IGF-2)
[21,36-38]. Together, these observations warrant the
investigation of steroid-receptor status of Notch2-lineage
traced L cells, and if they prove to be ER-positive, they
could be incorporated into the hormone-sensing lineage
of the stem cell hierarchy.
Overall, the Notch2-lineage tracing data and the ex-
periments presented here highlight that, as a rule, alveoli
develop through collaboration of different cell types
(Figure 7B-1) rather than being generated as clonal units
from a single progenitor. In the case of cooperative
growth, basal cells generate the basal cells of alveoli and
luminal alveolar progenitors such as PI-MECs produce
luminal ER-negative cells. Hormone-sensing cells may
be recruited in small numbers from the ducts and are
the likely instigators of alveolar outgrowth [20,21]. The
Axin2-lineage tracing data suggest that under certain
circumstances alveolar luminal and basal cells can derive
from the same source (Figure 7B-2). It will be interesting
to determine whether this includes ER-positive cells and
how these different modes for alveologenesis, collabor-
ation versus clonal origin, are regulated.
Conclusions
In intact mammary glands, PI-MECs are strictly luminal
and express markers of the secretory alveolar lineage. Not-
ably, an equipotent population of unlabeled alveolar pro-
genitors exists in primiparous glands, raising the question
of whether PI-MECs are a unique population or the result
of stochastic reporter activation. In line with other studies
that showed a more restricted lineage potential of other
stem/progenitor populations in intact mammary glands
compared with transplantation assays, we found that the
potential of PI-MECs in vivo is restricted to luminal ster-
oid receptor-negative cells. Our data underscore that indi-
vidual alveoli are not necessarily clonal and are frequentlyformed by cooperative outgrowth of cells from different
lineages, including at least one basal cell, one ER-positive
hormone-sensing cell, and one restricted luminal alveolar
progenitor cell such as a PI-MEC.Additional files
Additional file 1: Fluorescence-activated cell sorting (FACS)
antibodies used and gating strategy. (A) Antibodies used in FACS
isolation to separate luminal and basal populations (without Sca1) and
additionally separate hormone-sensing and alveolar populations (with
Sca1) of mammary epithelial cells. (B) Gating strategy for FACS analysis
and sorting.
Additional file 2: Polymerase chain reaction (PCR) primers used for
gene expression quantification by quantitative PCR (qPCR) and
RosaYFP locus recombination detection. YFP, yellow fluorescent
protein.
Additional file 3: Recombination of Rosa-lsl-YFP locus in pregnant
WapCre;Rosa-lsl-YFP glands. Genomic DNA was harvested from
mammary epithelial organoids from double transgenic mice (WapCre;
Rosa-lsl-YFP) at the indicated developmental time points. Polymerase
chain reaction (PCR) primers flanking the loxP sites of the Rosa26-lox-
Stop-lox-YFP locus amplify a 578-bp band only following Cre-mediated
recombination. The excision of the stop sequence was detectable at 7
days of the first pregnancy, although the extent of recombination was
variable between animals. Rosa-lsl-YFP, Rosa26-lox-Stop-lox-yellow
fluorescent protein.
Additional file 4: Analysis of parity-identified mammary epithelial
cell (PI-MEC) labeling in sequential pregnancies by wholemount
stereoscopy. Mouse thoracic mammary glands were dissected from
WAP-Cre;Rosa-lsl-YFP double transgenic mice at the following stages:
7 days (A) and 14 days (B) of the first pregnancy, 3 days of lactation (C),
involuted (>6 weeks after weaning) (D), and 7 days (E) and 14 days (F) of
the second pregnancy. Yellow fluorescent protein (YFP) fluorescence is
visualized by wholemount microscopy of unfixed mammary glands. Bar is
1 mm.
Additional file 5: Parity-identified mammary epithelial cell (PI-MEC)
cryosections close up. Close-up views of the high-magnification
confocal images from Figure 2, showing yellow fluorescent protein (YFP)
fluorescence (green) from cryosections counterstained with rhodamine-
conjugated phalloidin (red) and 4′,6-diamidino-2-phenylindole (DAPI)
(grey). WAP-Cre;Rosa-lsl-YFP mouse mammary glands were harvested at 7
days (A) and 14 days (B) of the first pregnancy, at 3 days of lactation (C),
at 6 weeks post-involution (D), and at 7 days (E) and 14 days (F) of the
second pregnancy. Scale bar is 10 μm. Rosa-lsl-YFP, Rosa26-lox-Stop-lox-
yellow fluorescent protein.
Additional file 6: Day 7 first pregnant mammary gland with
elevated parity-identified mammary epithelial cell (PI-MEC) labeling.
One day 7 first pregnant WapCre; RosaYFP mouse out of five displayed
extensive recombination and yellow fluorescent protein (YFP) expression
throughout ductal and alveolar network, seen by (A) wholemount
fluorescence of a thoracic gland and (B) fluorescence-activated cell
sorting (FACS) histogram of YFP fluorescence of mammary epithelial cells
from pooled abdominal and inguinal glands. Bar is 1 mm.
Additional file 7: Ductal labeling in a lactating gland. Enlarged
section of top panel of Figure 2C. Cryosection of a mammary gland
obtained 3 days post-partum from a WAP-Cre;Rosa-lsl-YFP mouse
showing yellow fluorescent protein (YFP) expression (green) and
counterstained with rhodamine-labeled phalloidin (red). Representative
confocal microscope image captured with a 20× objective lens. Arrows
point to unlabeled ductal cells and arrowheads to YFP-labeled ductal
cells. Scale bar is 50 μm.
Additional file 8: Quantitative polymerase chain reaction (qPCR)
identity of estrogen receptor-positive/yellow fluorescent protein-
positive (ER+/YFP+) double-positive cells in primiparous mammary
epithelial cells (MECs). Luminal single cells were isolated from parous
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before reverse transcriptase (RT) and qPCR. Rare YFPpos hormone-sensing
(HS) (Sca1hi CD49blo) cells (boxed in red) express similar levels of ERα and
progesterone receptor (PR) as YFPneg HS cells and do not express alveolar
marker genes Elf5 or β-Casein. Error bars reflect standard deviation (SD)
for alveolar samples of 500 cells from three individual mice. Note that the
HS data represent one tube of 500 cells from a pooled sample of five mice.
Additional file 9: Contribution of parity-identified mammary epithelial
cells (PI-MECs) to alveologenesis occurs in clusters. Cryosections of
mammary glands from WAP-Cre;Rosa-lsl-YFP mice at day 7 of the second
pregnancy showing yellow fluorescent protein (YFP) expression (green)
counterstained with rhodamine-conjugated phalloidin (red). Grey bar is
50 μm.
Additional file 10: Alveolar section map of a mammary gland at
day 7 of the second pregnancy. A cryosection of a thoracic mammary
gland was stained with rhodamine-conjugated phalloidin, imaged by
confocal microscopy in overlapping fields covering all alveoli within the
section, assembled into a contiguous map with Adobe Photoshop
(Adobe Systems, Mountain View, CA, USA), and scored for yellow fluorescent
protein (YFP) expression per alveolus. This mouse mammary gland
represents Figure 5B. Bar is 1 mm.
Additional file 11: Quantification of yellow fluorescent protein
(YFP)-positive alveoli. (A) Summary of tabulated raw alveoli counts for
mice scored in Figure 5D (at day 7 of the second pregnancy, A-B) and for
three mice at day 14 of their first pregnancy (X-Z, Figure 5E). (B) Confocal
images for mice X-Z showing the mainly partial labeling of alveoli at this
stage. Scale bar is 50 μm.
Additional file 12: Parity-identified mammary epithelial cells (PI-MECs)
generally do not generate hormone-sensing cells. Representative
confocal image of immunofluorescent staining of a paraffin section from
a day 7 second pregnancy gland showing a region where all luminal
(cytokeratin-8-positive, or CK8+, blue) estrogen receptor (ER)-negative
cells are derived from PI-MECs (green). In the same alveoli, the luminal
(CK8+, blue) cells that express the ER (ER+, red) are all yellow fluorescent
protein-negative (YFPneg). Scale bar is 10 μm.
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